Skip to main content
Erschienen in: Clinical Research in Cardiology 2/2017

19.12.2016 | Editorial

Thrombosis of TAVI prosthesis—cause for concern or innocent bystander? A comment and review of currently available data

verfasst von: Stephan H. Schirmer, Felix Mahfoud, Peter Fries, Bruno Scheller

Erschienen in: Clinical Research in Cardiology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

Transcatheter aortic valve implantation (TAVI) has become an established treatment option for severe aortic stenosis in patients at high risk of surgical aortic valve replacement [1, 2]. Recent studies, such as PARTNER-2 [3] and NOTION [4] have expanded the possible use of TAVI to patients at intermediate surgical risk. With increasing life expectancy of patients undergoing TAVI, the issue of valve durability becomes increasingly important. As yet, there is a paucity of data on the antithrombotic regimen following TAVI, although reports on many thousands TAVI procedures have been published [5], demonstrating excellent outcomes in all risk categories [6]. Until recently, much investigated safety issues in TAVI were risk of access vessel complications [7, 8], stroke, or pacemaker implantation, all of which have decreased substantially [912], resulting in an increasing global uptake of the approach. Changes in prosthesis leaflet morphology and function shortly after TAVI only gained interest in 2014, when a review of single case reports identified 16 clinical events of transcatheter valve thrombosis during 2002–2012 [13]. Increasing trans-valvular gradients on echocardiography (from 10 to 42 mmHg) were noted in these patients presented with dyspnea as the most common symptom. Anticoagulation with vitamin K antagonist (warfarin) effectively restored hemodynamics within 2 months. …
Literatur
1.
Zurück zum Zitat Haussig S, Schuler G, Linke A (2014) Worldwide TAVI registries: what have we learned? Clin Res Cardiol 103(8):603–612CrossRefPubMed Haussig S, Schuler G, Linke A (2014) Worldwide TAVI registries: what have we learned? Clin Res Cardiol 103(8):603–612CrossRefPubMed
2.
Zurück zum Zitat Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Mollmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB (2014) Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 103(8):631–640CrossRefPubMed Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Mollmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB (2014) Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 103(8):631–640CrossRefPubMed
3.
Zurück zum Zitat Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620CrossRefPubMed Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620CrossRefPubMed
4.
Zurück zum Zitat Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 65(20):2184–2194CrossRefPubMed Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 65(20):2184–2194CrossRefPubMed
5.
Zurück zum Zitat Mollmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck KH, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559CrossRefPubMed Mollmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck KH, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559CrossRefPubMed
6.
Zurück zum Zitat Biermann J, Horack M, Kahlert P, Schneider S, Nickenig G, Zahn R, Senges J, Erbel R, Wasem J, Neumann T (2015) The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry. Clin Res Cardiol 104(10):877–886CrossRefPubMed Biermann J, Horack M, Kahlert P, Schneider S, Nickenig G, Zahn R, Senges J, Erbel R, Wasem J, Neumann T (2015) The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry. Clin Res Cardiol 104(10):877–886CrossRefPubMed
7.
Zurück zum Zitat Geis NA, Chorianopoulos E, Kallenbach K, Andre F, Pleger ST, Karck M, Katus HA, Bekeredjian R (2014) Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters. Clin Res Cardiol 103(10):775–780CrossRefPubMed Geis NA, Chorianopoulos E, Kallenbach K, Andre F, Pleger ST, Karck M, Katus HA, Bekeredjian R (2014) Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters. Clin Res Cardiol 103(10):775–780CrossRefPubMed
8.
Zurück zum Zitat Seidler T, Hunlich M, Puls M, Hasenfuss G, Jacobshagen C (2016) Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation. Clin Res Cardiol. doi:10.1007/s00392-016-1038-1 PubMed Seidler T, Hunlich M, Puls M, Hasenfuss G, Jacobshagen C (2016) Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation. Clin Res Cardiol. doi:10.​1007/​s00392-016-1038-1 PubMed
9.
Zurück zum Zitat Abdul-Jawad Altisent O, Ferreira-Gonzalez I, Marsal JR, Ribera A, Auger C, Ortega G, Cascant P, Urena M, Del Blanco BG, Serra V, Sureda C, Igual A, Rovira A, Gonzalez-Alujas MT, Gonzalez A, Puri R, Cuellar H, Tornos P, Rodes-Cabau J, Garcia-Dorado D (2016) Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients. Clin Res Cardiol 105(6):508–517CrossRefPubMed Abdul-Jawad Altisent O, Ferreira-Gonzalez I, Marsal JR, Ribera A, Auger C, Ortega G, Cascant P, Urena M, Del Blanco BG, Serra V, Sureda C, Igual A, Rovira A, Gonzalez-Alujas MT, Gonzalez A, Puri R, Cuellar H, Tornos P, Rodes-Cabau J, Garcia-Dorado D (2016) Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients. Clin Res Cardiol 105(6):508–517CrossRefPubMed
10.
Zurück zum Zitat Kim WK, Liebetrau C, van Linden A, Blumenstein J, Gaede L, Hamm CW, Walther T, Mollmann H (2016) Myocardial injury associated with transcatheter aortic valve implantation (TAVI). Clin Res Cardiol 105(5):379–387CrossRefPubMed Kim WK, Liebetrau C, van Linden A, Blumenstein J, Gaede L, Hamm CW, Walther T, Mollmann H (2016) Myocardial injury associated with transcatheter aortic valve implantation (TAVI). Clin Res Cardiol 105(5):379–387CrossRefPubMed
11.
Zurück zum Zitat Samim M, Hendrikse J, van der Worp HB, Agostoni P, Nijhoff F, Doevendans PA, Stella PR (2015) Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors. Clin Res Cardiol 104(5):430–438CrossRefPubMed Samim M, Hendrikse J, van der Worp HB, Agostoni P, Nijhoff F, Doevendans PA, Stella PR (2015) Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors. Clin Res Cardiol 104(5):430–438CrossRefPubMed
12.
Zurück zum Zitat Weber M, Bruggemann E, Schueler R, Momcilovic D, Sinning JM, Ghanem A, Werner N, Grube E, Schiller W, Mellert F, Welz A, Nickenig G, Hammerstingl C (2015) Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR. Clin Res Cardiol 104(11):964–974CrossRefPubMed Weber M, Bruggemann E, Schueler R, Momcilovic D, Sinning JM, Ghanem A, Werner N, Grube E, Schiller W, Mellert F, Welz A, Nickenig G, Hammerstingl C (2015) Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR. Clin Res Cardiol 104(11):964–974CrossRefPubMed
13.
Zurück zum Zitat Cordoba-Soriano JG, Puri R, Amat-Santos I, Ribeiro HB, Abdul-Jawad Altisent O, del Trigo M, Paradis JM, Dumont E, Urena M, Rodes-Cabau J (2015) Valve thrombosis following transcatheter aortic valve implantation: a systematic review. Revista espanola de cardiologia (English ed) 68(3):198–204 Cordoba-Soriano JG, Puri R, Amat-Santos I, Ribeiro HB, Abdul-Jawad Altisent O, del Trigo M, Paradis JM, Dumont E, Urena M, Rodes-Cabau J (2015) Valve thrombosis following transcatheter aortic valve implantation: a systematic review. Revista espanola de cardiologia (English ed) 68(3):198–204
14.
Zurück zum Zitat Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42(5):S45–S60CrossRefPubMed Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42(5):S45–S60CrossRefPubMed
15.
Zurück zum Zitat Leetmaa T, Hansson NC, Leipsic J, Jensen K, Poulsen SH, Andersen HR, Jensen JM, Webb J, Blanke P, Tang M, Norgaard BL (2015) Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv 8(4):e001596CrossRefPubMed Leetmaa T, Hansson NC, Leipsic J, Jensen K, Poulsen SH, Andersen HR, Jensen JM, Webb J, Blanke P, Tang M, Norgaard BL (2015) Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv 8(4):e001596CrossRefPubMed
16.
Zurück zum Zitat Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, de Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Sondergaard L (2015) Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373(21):2015–2024CrossRefPubMed Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, de Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Sondergaard L (2015) Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373(21):2015–2024CrossRefPubMed
17.
Zurück zum Zitat Del Trigo M, Munoz-Garcia AJ, Wijeysundera HC, Nombela-Franco L, Cheema AN, Gutierrez E, Serra V, Kefer J, Amat-Santos IJ, Benitez LM, Mewa J, Jimenez-Quevedo P, Alnasser S, Garcia Del Blanco B, Dager A, Abdul-Jawad Altisent O, Puri R, Campelo-Parada F, Dahou A, Paradis JM, Dumont E, Pibarot P, Rodes-Cabau J (2016) Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol 67(6):644–655CrossRefPubMed Del Trigo M, Munoz-Garcia AJ, Wijeysundera HC, Nombela-Franco L, Cheema AN, Gutierrez E, Serra V, Kefer J, Amat-Santos IJ, Benitez LM, Mewa J, Jimenez-Quevedo P, Alnasser S, Garcia Del Blanco B, Dager A, Abdul-Jawad Altisent O, Puri R, Campelo-Parada F, Dahou A, Paradis JM, Dumont E, Pibarot P, Rodes-Cabau J (2016) Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol 67(6):644–655CrossRefPubMed
18.
Zurück zum Zitat Milburn K, Bapat V, Thomas M (2014) Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature. Clin Res Cardiol 103(6):417–429CrossRefPubMed Milburn K, Bapat V, Thomas M (2014) Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature. Clin Res Cardiol 103(6):417–429CrossRefPubMed
19.
Zurück zum Zitat Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, Baumgartner H, Finkelstein A, Legrand V, de Lezo JS, Kefer J, Messika-Zeitoun D, Richardt G, Stabile E, Kaleschke G, Vahanian A, Laborde JC, Leon MB, Webb JG, Panoulas VF, Maisano F, Alfieri O, Colombo A (2015) Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv 8(4):e001779CrossRefPubMed Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, Baumgartner H, Finkelstein A, Legrand V, de Lezo JS, Kefer J, Messika-Zeitoun D, Richardt G, Stabile E, Kaleschke G, Vahanian A, Laborde JC, Leon MB, Webb JG, Panoulas VF, Maisano F, Alfieri O, Colombo A (2015) Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv 8(4):e001779CrossRefPubMed
20.
Zurück zum Zitat Hansson NC, Grove EL, Andersen HR, Leipsic J, Mathiassen ON, Jensen JM, Jensen KT, Blanke P, Leetmaa T, Tang M, Krusell LR, Klaaborg KE, Christiansen EH, Terp K, Terkelsen CJ, Poulsen SH, Webb J, Botker HE, Norgaard BL (2016) Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol 68(19):2059–2069CrossRefPubMed Hansson NC, Grove EL, Andersen HR, Leipsic J, Mathiassen ON, Jensen JM, Jensen KT, Blanke P, Leetmaa T, Tang M, Krusell LR, Klaaborg KE, Christiansen EH, Terp K, Terkelsen CJ, Poulsen SH, Webb J, Botker HE, Norgaard BL (2016) Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol 68(19):2059–2069CrossRefPubMed
21.
Zurück zum Zitat Ruile P, Jander N, Blanke P, Schoechlin S, Reinohl J, Gick M, Rothe J, Langer M, Leipsic J, Buettner HJ, Neumann FJ, Pache G (2016) Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation. Clin Res Cardiol. doi:10.1007/s00392-016-1052-3 PubMed Ruile P, Jander N, Blanke P, Schoechlin S, Reinohl J, Gick M, Rothe J, Langer M, Leipsic J, Buettner HJ, Neumann FJ, Pache G (2016) Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation. Clin Res Cardiol. doi:10.​1007/​s00392-016-1052-3 PubMed
22.
Zurück zum Zitat Pache G, Schoechlin S, Blanke P, Dorfs S, Jander N, Arepalli CD, Gick M, Buettner HJ, Leipsic J, Langer M, Neumann FJ, Ruile P (2016) Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J 37(28):2263–2271CrossRefPubMed Pache G, Schoechlin S, Blanke P, Dorfs S, Jander N, Arepalli CD, Gick M, Buettner HJ, Leipsic J, Langer M, Neumann FJ, Ruile P (2016) Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J 37(28):2263–2271CrossRefPubMed
23.
Zurück zum Zitat Yadlapati A, Groh C, Malaisrie SC, Gajjar M, Kruse J, Meyers S, Passman R (2016) Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves. Clin Res Cardiol 105(3):268–272CrossRefPubMed Yadlapati A, Groh C, Malaisrie SC, Gajjar M, Kruse J, Meyers S, Passman R (2016) Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves. Clin Res Cardiol 105(3):268–272CrossRefPubMed
24.
Zurück zum Zitat Pibarot P, Dumesnil JG (2009) Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 119(7):1034–1048CrossRefPubMed Pibarot P, Dumesnil JG (2009) Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 119(7):1034–1048CrossRefPubMed
25.
Zurück zum Zitat Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ, Connolly HM (2015) Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol 66(21):2285–2294CrossRefPubMed Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ, Connolly HM (2015) Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol 66(21):2285–2294CrossRefPubMed
26.
Zurück zum Zitat Capodanno D (2016) Transcatheter aortic valve durability and the dark side of Kaplan–Meier analysis. EuroIntervention 12(7):821–822CrossRefPubMed Capodanno D (2016) Transcatheter aortic valve durability and the dark side of Kaplan–Meier analysis. EuroIntervention 12(7):821–822CrossRefPubMed
27.
Zurück zum Zitat Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG (2015) 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484CrossRefPubMed Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG (2015) 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484CrossRefPubMed
29.
Zurück zum Zitat Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal Mdel R, Marsal JR, Campelo-Parada F, Regueiro A, Del Trigo M, Dumont E, Puri R, Rodes-Cabau J (2016) Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 9(16):1706–1717CrossRefPubMed Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal Mdel R, Marsal JR, Campelo-Parada F, Regueiro A, Del Trigo M, Dumont E, Puri R, Rodes-Cabau J (2016) Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 9(16):1706–1717CrossRefPubMed
30.
Zurück zum Zitat Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496CrossRefPubMed Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496CrossRefPubMed
31.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):2438–2488CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):2438–2488CrossRefPubMed
Metadaten
Titel
Thrombosis of TAVI prosthesis—cause for concern or innocent bystander? A comment and review of currently available data
verfasst von
Stephan H. Schirmer
Felix Mahfoud
Peter Fries
Bruno Scheller
Publikationsdatum
19.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 2/2017
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1061-2

Weitere Artikel der Ausgabe 2/2017

Clinical Research in Cardiology 2/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.